Pain Measured by NRS and EEG in Acute Pulpitis

Last updated: July 29, 2024
Sponsor: Cleveland Dental Institute
Overall Status: Active - Recruiting

Phase

N/A

Condition

Acute And Chronic Dental Pain

Treatment

Brain wave analysis using electroencephalography (EEG).

Numerical rate Scale (NRS)

Clinical Study ID

NCT06526572
CDIENDO0007
  • Ages 18-50
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

The aim of the proposed study is to investigate and comprehensively understand pain perception in patients diagnosed with symptomatic acute pulpitis who are resistant to inferior alveolar nerve block (IANB).

The study aims to achieve this by utilizing a dual approach that combines subjective self-reporting of pain intensity using the Numeric Rating Scale (NRS) with objective neurophysiological assessment through brain wave analysis using electroencephalography (EEG).

By integrating these two methods, the study seeks to explore potential correlations between self-reported pain scores and neural responses recorded through EEG, providing insights into the pain experience of this specific patient population.

Ultimately, the goal of the study is to enhance the understanding of pain perception mechanisms in individuals with symptomatic acute pulpitis resistant to IANB and potentially guide the development of more effective and personalized pain management strategies for these patients.

Eligibility Criteria

Inclusion

Inclusion Criteria:

Adults aged [18-50 years]. Clinically diagnosed with symptomatic acute pulpitis based on dental examination and radiographic findings.

Demonstrates resistance to inferior alveolar nerve block (IANB). Willing and able to provide informed consent to participate in the study. Able to communicate effectively in the language used for study procedures.

Exclusion

Exclusion Criteria:

Individuals with known neurological or psychiatric disorders affecting pain perception.

Pregnant individuals or those breastfeeding at the time of the study. History of severe allergies or adverse reactions to local anesthetics or EEG gel.

Presence of significant medical conditions that may contraindicate dental procedures or EEG recordings.

Individuals taking medications that could significantly affect pain perception (e.g., strong analgesics, sedatives).

Any contraindications for dental procedures or EEG recordings as determined by the study's dental and medical professionals.

Inability to understand and follow study instructions.

Study Design

Total Participants: 50
Treatment Group(s): 2
Primary Treatment: Brain wave analysis using electroencephalography (EEG).
Phase:
Study Start date:
July 01, 2023
Estimated Completion Date:
January 31, 2025

Connect with a study center

  • Cleveland Dental Institute

    Cleveland, Ohio 44128
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.